Xilio Therapeutics, Inc.
Related Filers (55)
- Russo Rene (8)
- Huber Martin H. Jr. (7)
- Atlas Venture Fund XI, L.P. (5)
- Flynn James E (5)
- FMR LLC (5)
- Atlas Venture Opportunity Fund I, L.P. (4)
- SV7 Impact Medicine Fund LP (4)
- Bain Capital Life Sciences Fund II, L.P. (4)
- Clancy Paul J (4)
- Xu Yuan (4)
- Brennan Kevin M. (4)
- Frankenfield Christopher James (4)
- Atlas Venture Associates Opportunity I, LLC (3)
- Atlas Venture Associates XI, LLC (3)
- Atlas Venture Associates XI, L.P. (3)
- Atlas Venture Associates Opportunity I, L.P. (3)
- Rock Springs Capital Management LP (3)
- RiverVest Venture Fund IV, L.P. (3)
- TAKEDA PHARMACEUTICAL CO LTD (3)
- SV7 (IMF) GP LLP (3)
- Giovine Salvatore (3)
- Ross Michael Jay (3)
- RA CAPITAL MANAGEMENT, L.P. (3)
- Octagon Capital Advisors LP (3)
- Bonstein Sara (3)
- ROSS ROBERT W. (3)
- Heyman Tomas J. (3)
- Rossi Christina (3)
- Luptakova Katarina (3)
- Alexandria Venture Investments, LLC (2)
- Merck KGaA (2)
- Four Pines Master Fund LP (2)
- BAY CITY CAPITAL LLC (2)
- Rock Springs Capital LLC (2)
- Takeda Ventures, Inc. (2)
- Rock Springs Capital Master Fund LP (2)
- DEERFIELD PARTNERS, L.P. (2)
- DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2)
- Deerfield Mgmt V, L.P. (2)
- FIL Ltd (2)
- Deerfield Mgmt L.P. (2)
- BCLS II Investo (GP), LLC (2)
- Bain Capital Life Sciences Investors II, LLC (2)
- Bain Capital Life Sciences Investors, LLC (2)
- BCLS II Investco, LP (2)
- BCIP Life Sciences Associates, LP (2)
- English Edward C (2)
- TOMLINSON SIMON M (1)
- Estate of Ulrich Rodeck (1)
- CLACKSON TIMOTHY P (1)
- LYNCH DANIEL (1)
- Curran Daniel J. (1)
- HUMPHREY RACHEL (1)
- Williams John Charles (1)
- MRL Ventures Fund LLC (1)
- Show More ...
Financials (12)
10-Q/A
Thursday, 11/9/2023
Quarterly Report for period ending 2023-06-30
10-Q/A
Thursday, 11/9/2023
Quarterly Report for period ending 2023-03-31
10-Q
Thursday, 11/9/2023
Quarterly Report for period ending 2023-09-30
10-K/A
Thursday, 11/9/2023
Annual Report for period ending 2022-12-31
10-Q
Monday, 8/14/2023
Quarterly Report for period ending 2023-06-30
10-Q
Tuesday, 5/9/2023
Quarterly Report for period ending 2023-03-31
10-K
Thursday, 3/2/2023
Annual Report for period ending 2022-12-31
10-Q
Wednesday, 11/9/2022
Quarterly Report for period ending 2022-09-30
10-Q
Tuesday, 8/9/2022
Quarterly Report for period ending 2022-06-30
10-Q
Thursday, 5/12/2022
Quarterly Report for period ending 2022-03-31
10-K
Tuesday, 3/1/2022
Annual Report for period ending 2021-12-31
10-Q
Thursday, 12/2/2021
Quarterly Report for period ending 2021-09-30
News (27)
8-K
Friday, 1/19/2024
Current report filing
8-K
Wednesday, 1/3/2024
Current report filing
8-K
Thursday, 12/7/2023
Current report filing
8-K
Thursday, 11/9/2023
Current report filing
8-K
Friday, 11/3/2023
Current report filing
8-K
Tuesday, 9/5/2023
Current report filing
8-K
Monday, 8/14/2023
Current report filing
8-K
Thursday, 8/3/2023
Current report filing
8-K
Tuesday, 6/13/2023
Current report filing
8-K
Thursday, 5/25/2023
Current report filing
8-K
Tuesday, 5/9/2023
Current report filing
8-K
Monday, 4/3/2023
Current report filing
8-K
Thursday, 3/2/2023
Current report filing
8-K
Monday, 1/9/2023
Current report filing
8-K
Friday, 12/23/2022
Current report filing
8-K
Wednesday, 11/9/2022
Current report filing
8-K
Thursday, 9/15/2022
Current report filing
8-K
Tuesday, 8/9/2022
Current report filing
8-K
Thursday, 7/28/2022
Current report filing
8-K
Thursday, 6/16/2022
Current report filing
8-K
Monday, 6/13/2022
Current report filing
8-K
Thursday, 5/12/2022
Current report filing
8-K
Tuesday, 3/1/2022
Current report filing
8-K
Friday, 2/4/2022
Current report filing
8-K
Thursday, 1/6/2022
Current report filing
8-K
Thursday, 12/2/2021
Current report filing
8-K
Tuesday, 10/26/2021
Current report filing
Other (14)
ARS
Tuesday, 4/25/2023
Annual report to security holders
EFFECT
Friday, 11/18/2022
Notice of Effectiveness
CORRESP
Wednesday, 11/16/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
SEC STAFF LETTER
Friday, 10/22/2021
None
CERT
Thursday, 10/21/2021
Certification by an exchange approving securities for listing
EFFECT
Thursday, 10/21/2021
Notice of Effectiveness
CORRESP
Tuesday, 10/19/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 10/19/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 10/18/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
8-A12B
Monday, 10/18/2021
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CORRESP
Friday, 10/1/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
SEC STAFF LETTER
Friday, 6/25/2021
None
D
Friday, 2/26/2021
Exempt (Private) Offering
D
Thursday, 1/21/2021
Exempt (Private) Offering
Ownership (108)
SC 13G
Wednesday, 2/14/2024
Rock Springs Capital Management LP: Major Shareholders
4
Friday, 2/9/2024
Atlas Venture Fund XI, L.P.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/6/2024
Octagon Capital Advisors LP: Major Shareholders
SC 13G/A
Monday, 2/5/2024
Octagon Capital Advisors LP: Major Shareholders
4
Tuesday, 1/16/2024
Atlas Venture Fund XI, L.P.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/3/2024
Luptakova Katarina: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/3/2024
Frankenfield Christopher James: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/3/2024
Russo Rene: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/3/2024
Brennan Kevin M.: Statement of changes in beneficial ownership of securities
3
Thursday, 9/7/2023
Luptakova Katarina: Initial statement of beneficial ownership of securities
4
Thursday, 9/7/2023
Luptakova Katarina: Statement of changes in beneficial ownership of securities
4
Friday, 8/18/2023
Frankenfield Christopher James: Statement of changes in beneficial ownership of securities
4
Friday, 8/18/2023
Russo Rene: Statement of changes in beneficial ownership of securities
4
Friday, 8/18/2023
Brennan Kevin M.: Statement of changes in beneficial ownership of securities
4
Friday, 8/18/2023
Huber Martin H. Jr.: Statement of changes in beneficial ownership of securities
4
Monday, 8/7/2023
Frankenfield Christopher James: Statement of changes in beneficial ownership of securities
3
Monday, 8/7/2023
Frankenfield Christopher James: Initial statement of beneficial ownership of securities
4
Tuesday, 6/13/2023
Clancy Paul J: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
Bonstein Sara: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
Rossi Christina: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
ROSS ROBERT W.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
Heyman Tomas J.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
Xu Yuan: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 4/10/2023
MRL Ventures Fund LLC: Major Shareholders
3
Monday, 4/3/2023
Brennan Kevin M.: Initial statement of beneficial ownership of securities
4
Monday, 4/3/2023
Brennan Kevin M.: Statement of changes in beneficial ownership of securities
SC 13G/A
Thursday, 2/9/2023
FMR LLC: Major Shareholders
SC 13G
Wednesday, 1/25/2023
Octagon Capital Advisors LP: Major Shareholders
4
Wednesday, 1/4/2023
Russo Rene: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/4/2023
Huber Martin H. Jr.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/4/2023
English Edward C: Statement of changes in beneficial ownership of securities
SC 13G/A
Thursday, 12/29/2022
Flynn James E: Major Shareholders
3
Wednesday, 11/16/2022
English Edward C: Initial statement of beneficial ownership of securities
SC 13G/A
Monday, 11/14/2022
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
4
Friday, 9/16/2022
Heyman Tomas J.: Statement of changes in beneficial ownership of securities
3
Friday, 9/16/2022
Heyman Tomas J.: Initial statement of beneficial ownership of securities
4/A
Thursday, 6/23/2022
Huber Martin H. Jr.: Statement of changes in beneficial ownership of securities
4
Friday, 6/17/2022
Bonstein Sara: Statement of changes in beneficial ownership of securities
4
Friday, 6/17/2022
Ross Michael Jay: Statement of changes in beneficial ownership of securities
4
Friday, 6/17/2022
Clancy Paul J: Statement of changes in beneficial ownership of securities
4
Friday, 6/17/2022
ROSS ROBERT W.: Statement of changes in beneficial ownership of securities
4
Friday, 6/17/2022
Rossi Christina: Statement of changes in beneficial ownership of securities
3
Friday, 6/17/2022
ROSS ROBERT W.: Initial statement of beneficial ownership of securities
4
Friday, 6/17/2022
Huber Martin H. Jr.: Statement of changes in beneficial ownership of securities
4
Friday, 6/17/2022
Xu Yuan: Statement of changes in beneficial ownership of securities
4
Thursday, 2/24/2022
Russo Rene: Statement of changes in beneficial ownership of securities
4
Thursday, 2/24/2022
Huber Martin H. Jr.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/24/2022
Giovine Salvatore: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/14/2022
Bain Capital Life Sciences Fund II, L.P.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
SC 13G/A
Friday, 2/11/2022
Flynn James E: Major Shareholders
SC 13G/A
Wednesday, 2/9/2022
FMR LLC: Major Shareholders
SC 13G
Friday, 1/14/2022
TAKEDA PHARMACEUTICAL CO LTD: Major Shareholders
3
Thursday, 1/6/2022
Xu Yuan: Initial statement of beneficial ownership of securities
4
Thursday, 1/6/2022
Xu Yuan: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 1/4/2022
Russo Rene: Statement of changes in beneficial ownership of securities
4
Thursday, 12/23/2021
Russo Rene: Statement of changes in beneficial ownership of securities
4
Friday, 12/10/2021
BCIP Life Sciences Associates, LP: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 11/5/2021
Bain Capital Life Sciences Fund II, L.P.: Major Shareholders
SC 13G
Friday, 11/5/2021
RA CAPITAL MANAGEMENT, L.P.: Major Shareholders
3
Friday, 11/5/2021
BCIP Life Sciences Associates, LP: Initial statement of beneficial ownership of securities
SC 13G
Friday, 11/5/2021
Atlas Venture Fund XI, L.P.: Major Shareholders
SC 13D
Friday, 11/5/2021
RiverVest Venture Fund IV, L.P.: Major Shareholders
SC 13G
Thursday, 11/4/2021
FMR LLC: Major Shareholders
SC 13D
Wednesday, 11/3/2021
SV7 Impact Medicine Fund LP: Major Shareholders
4/A
Wednesday, 11/3/2021
SV7 Impact Medicine Fund LP: Statement of changes in beneficial ownership of securities
4
Thursday, 10/28/2021
FMR LLC: Statement of changes in beneficial ownership of securities
4
Thursday, 10/28/2021
FIL Ltd: Statement of changes in beneficial ownership of securities
4
Thursday, 10/28/2021
SV7 Impact Medicine Fund LP: Statement of changes in beneficial ownership of securities
4
Thursday, 10/28/2021
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): Statement of changes in beneficial ownership of securities
SC 13G
Wednesday, 10/27/2021
Flynn James E: Major Shareholders
4
Tuesday, 10/26/2021
Rock Springs Capital Management LP: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/26/2021
Merck KGaA: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/26/2021
TAKEDA PHARMACEUTICAL CO LTD: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/26/2021
Clancy Paul J: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/26/2021
Alexandria Venture Investments, LLC: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/26/2021
Atlas Venture Fund XI, L.P.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/26/2021
BAY CITY CAPITAL LLC: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/26/2021
RiverVest Venture Fund IV, L.P.: Statement of changes in beneficial ownership of securities
4
Monday, 10/25/2021
Ross Michael Jay: Statement of changes in beneficial ownership of securities
4
Monday, 10/25/2021
Huber Martin H. Jr.: Statement of changes in beneficial ownership of securities
4
Monday, 10/25/2021
Russo Rene: Statement of changes in beneficial ownership of securities
4
Monday, 10/25/2021
Giovine Salvatore: Statement of changes in beneficial ownership of securities
3
Friday, 10/22/2021
Williams John Charles: Initial statement of beneficial ownership of securities
3
Thursday, 10/21/2021
Giovine Salvatore: Initial statement of beneficial ownership of securities
3
Thursday, 10/21/2021
Alexandria Venture Investments, LLC: Initial statement of beneficial ownership of securities
3
Thursday, 10/21/2021
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): Initial statement of beneficial ownership of securities
3
Thursday, 10/21/2021
CLACKSON TIMOTHY P: Initial statement of beneficial ownership of securities
3
Thursday, 10/21/2021
HUMPHREY RACHEL: Initial statement of beneficial ownership of securities
3
Thursday, 10/21/2021
Ross Michael Jay: Initial statement of beneficial ownership of securities
3
Thursday, 10/21/2021
Rock Springs Capital Management LP: Initial statement of beneficial ownership of securities
3
Thursday, 10/21/2021
SV7 Impact Medicine Fund LP: Initial statement of beneficial ownership of securities
3
Thursday, 10/21/2021
Atlas Venture Fund XI, L.P.: Initial statement of beneficial ownership of securities
3
Thursday, 10/21/2021
Rossi Christina: Initial statement of beneficial ownership of securities
3
Thursday, 10/21/2021
Clancy Paul J: Initial statement of beneficial ownership of securities
3
Thursday, 10/21/2021
BAY CITY CAPITAL LLC: Initial statement of beneficial ownership of securities
3
Thursday, 10/21/2021
Curran Daniel J.: Initial statement of beneficial ownership of securities
3
Thursday, 10/21/2021
Bonstein Sara: Initial statement of beneficial ownership of securities
3
Thursday, 10/21/2021
Merck KGaA: Initial statement of beneficial ownership of securities
3
Thursday, 10/21/2021
Huber Martin H. Jr.: Initial statement of beneficial ownership of securities
Prospectus (11)
S-8
Thursday, 3/2/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-3
Wednesday, 11/9/2022
Registration statement for specified transactions by certain issuers
S-8
Tuesday, 3/1/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Monday, 10/25/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Friday, 10/22/2021
Prospectus filed pursuant to Rule 424(b)(4)
S-1/A
Wednesday, 10/20/2021
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Monday, 10/18/2021
General form of registration statement for all companies including face-amount certificate companies
S-1
Friday, 10/1/2021
General form of registration statement for all companies including face-amount certificate companies
DRSLTR
Tuesday, 9/14/2021
Correspondence Related to Draft Registration Statement
DRS/A
Tuesday, 9/14/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS
Monday, 5/24/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Proxies (4)
DEF 14A
Tuesday, 4/25/2023
Definitive proxy statements
DEFA14A
Tuesday, 4/25/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Tuesday, 4/26/2022
Definitive proxy statements
DEFA14A
Tuesday, 4/26/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.